搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
来自MSN
1 小时
NYU develops new drug that attacks cancer cells without harming healthy ones
But despite causing major diseases, these slightly mutated proteins can resemble their normal versions so closely that ...
ScienceAlert
1 小时
Unexpected Link Between Menthol And Alzheimer's Discovered in Mice
In mice with Alzheimer's, the course of menthol for a six-month-long period was enough to stop the cognitive abilities and ...
3 小时
Q&A on the 2024-2025 COVID-19 Vaccines
Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...
GEN
4 小时
New CEO Leads CRI’s Fight vs. Cancer: “People x Biology x Data”
Alicia Zhou, PhD, became CRI’s president effective August 26, and succeeded Jill O’Donnell-Tormey, PhD, who had led the Institute since 1993.
mskcc.org
5 小时
Do Mushroom Supplements Boost Immunity Against Cancer?
Dr. Gary Deng of the Integrative Medicine Service helps separate the hype from the proven health benefits of mushroom ...
Psychology Today
5 小时
Influence of Stress on Calorie-Restricted Diets and Lifespan
Psychological stress can undermine the positive effects of calorie-restricted diets by suppressing immune function, which ...
6 小时
BriaCell Therapeutics: High-Potential In Phase 3 Metastatic Breast Cancer, But Financing ...
BriaCell Therapeutics could access a $1-$5 billion market upon approval despite a sub-$30 million cap. See more on BRIA stock ...
6 小时
on MSN
Metformin for rare skin cancer treatment: Research shows drug's unique ability to impact ...
Dermatofibrosarcoma protuberans (DFSP) is a rare skin sarcoma known for its high recurrence rates, making treatment ...
Science Daily
7 小时
How the coronavirus defeats the innate immune response
SARS-CoV-2 has an enzyme that can counteract a cell's innate defense mechanism against viruses, explaining why it is more ...
Frontiers
11 小时
Advances in Immune Cell Engineering for Treating Cancers and Other Diseases
Indeed, early clinical studies suggest that CAR T-cells can send autoimmune disorders into remission with fewer side effects, like cytokine release syndrome and neurotoxicity, as commonly seen in ...
13 小时
TuHURA Biosciences (NASDAQ:HURA) to Present at the Virtual Investor “New to the Street ...
Live moderated webcast with Dr. Jim Bianco, President and Chief Executive Officer of TuHURA on Wednesday, October 30th ...
16 小时
NYU’s Next-Gen Cancer Therapy Precisely Attacks Mutant Proteins
Scientists at NYU have created a drug that targets cancer-causing HER2 mutations without harming healthy cells. This new ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈